株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ヒトES細胞の世界市場

Human Embryonic Stem Cells Market - Growth, Trends, and Forecast (2020 - 2025)

発行 Mordor Intelligence LLP 商品コード 567966
出版日 ページ情報 英文 120 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.95円で換算しております。
ヒトES細胞の世界市場 Human Embryonic Stem Cells Market - Growth, Trends, and Forecast (2020 - 2025)
出版日: 2020年02月01日 ページ情報: 英文 120 Pages
担当者のコメント
下記の日本語概要は、最新版レポートの内容と異なる場合があります。詳細はお問合せください。
概要

当レポートでは、ヒトES細胞の世界市場について調査し、市場の概要、応用領域・地域別の市場動向、市場促進・阻害要因および課題の分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 イントロダクション

  • 市場の定義
  • 調査手法

第2章 エグゼクティブサマリー

第3章 主な推論

第4章 市場概要

  • 市場概況
  • ファイブフォース分析

第5章 市場力学

  • 促進要因
  • 阻害要因
  • 市場機会
  • 課題

第6章 市場区分

  • ヒトES細胞の世界市場:応用領域別
    • 再生医療
    • 幹細胞生物学
    • ティッシュエンジニアリング
    • 毒性試験
  • ヒトES細胞の世界市場:地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
    • 南米

第7章 競合情勢

  • 合併・買収
  • 新製品の投入
  • 合意・提携・協力

第8章 企業プロファイル

  • Australian Stem Cell Centre
  • BD Biosciences
  • Cellartis AB
  • Millipore Corporation
  • Geron Corporation
  • Invitrogen Corporation
  • Viacyte
  • SA Biosciences Corporation
  • Tataa Biocenter
  • Thermo Scientific
  • Vitrolife AB

第9章 市場の将来展望

目次
Product Code: 54446

The government funding for the development of regenerative medicine has been increasing in most developed countries, because of its applications in organ transplantation, tissue engineering, and various other applications. In the United States, two major government agencies, National Institutes of Health (NIH) and California Institute of Regenerative Medicine (CIRM), fund almost all the translational researches and regenerative medicine development in the country. It is estimated that the United States government invests around USD 800-900 million every year in stem cell research. Additionally, other factors such as the high prevalence of cardiac and malignant diseases, and rising demand for regenerative medicines are expected to drive the market.

Key Market Trends

Stem Cell Biology Research Segment is Expected to Show Better Growth in the Forecast Years

Based on the application, it is segmented into regenerative medicine, stem cell biology research, tissue engineering, and toxicology testing. Stem cell biology research will show better growth, owing to the high prevalence of cardiac and malignant diseases. An article published by the ISSCR (International Society for Stem Cell Research) reported that the stem cells hold potential for the treatment of Parkinson's disease in humans. Recently, one of the market players, International Stem Cell Corporation (ISCO), received the patent covering methods for generating HLA homozygous parthenogenetic human stem cell lines from unfertilized eggs. The patent was issued in Australia. Furthermore, to boost the pace of stem cell research, the government is providing funding opportunities to researchers. Thus, owing to these factors, the market studied is expected to witness a high growth rate over the forecast period.

North America Dominates the Human Embryonic Stem Cells Market

The human embryonic stem cells market is expected to dominate in the North America region owing to extensive research activities, along with high burden of chronic diseases and genetic disorders in the region. The United States also shows a high incidence of other diseases, such as diabetes, heart disease, renal failure, and osteoporosis. Human embryonic stem cells have high potential for use in treatment and may become a standard of care for these diseases. Additionally, the FDA has approved clinical trials, which indicated the use of stem cells. Hence, these factors are expected to influence the growth of the human embryonic stem cells market over the forecast period.

Competitive Landscape

The global players into the human embryonic stem cells market are Becton, Dickinson and Company, Cynata Therapeutics Limited, ESI BIO, Geron Corporation, International Stem Cell Corporation, Merck KGaA, PromoCell GmbH, STEMCELL Technologies Inc, Thermo Fisher Scientific and ViaCyte, Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Prevalence of Cardiac and Malignant Diseases
    • 4.2.2 Rising Demand for Regenerative Medicines
    • 4.2.3 Increasing Support from Governments and Government and Private Institutions
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Procedure
    • 4.3.2 Stringent Regulatory Guidelines
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Application
    • 5.1.1 Regenerative Medicine
    • 5.1.2 Stem Cell Biology Research
    • 5.1.3 Tissue Engineering
    • 5.1.4 Toxicology Testing
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Rest of World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Becton, Dickinson and Company
    • 6.1.2 Cynata Therapeutics Limited
    • 6.1.3 ESI BIO
    • 6.1.4 Geron Corporation
    • 6.1.5 International Stem Cell Corporation
    • 6.1.6 Merck KGaA
    • 6.1.7 PromoCell GmbH
    • 6.1.8 STEMCELL Technologies Inc
    • 6.1.9 Thermo Fisher Scientific
    • 6.1.10 ViaCyte, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS